BioSpace News Archive

Curate Biosciences announced the first outcome of its Technology Access Program, which is dedicated to converting research into real-world treatments and cures as rapidly as possible.

Apnimed announced that company management will participate in 1x1 investor meetings at the 21st Needham Healthcare Conference taking place virtually April 11-14, 2022.

NewAmsterdam Pharma (NAP) today announced dose administration for the first patient in ROSE2, the Company’s Phase 2 trial of obicetrapib, a novel cholesteryl ester transfer protein (CETP) inhibitor.

Sofinnova Investments announced today the addition of Chris Carpenter, M.D., Ph.D., to the investment team as an Executive Partner.

KSL Diagnostics, Inc. has launched a first-of-its-kind antibody test that detects an individual’s immune response to COVID-19 and assesses the risk of infection if subsequently exposed.

Oramed Pharmaceuticals Inc. today announced that the European Patent Office has granted the Company the patent titled “Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof.”

Processa Pharmaceuticals, Inc. announced today that it has enrolled its first patient in the Phase 2A clinical trial of PCS12852 in patients with moderate to severe gastroparesis.

CNS Pharmaceuticals, Inc. today announced it has received approval from Swissmedic, the Swiss Agency for Therapeutic Products, for the Company’s potentially pivotal study of Berubicin.

PathAI, a global leader in AI-powered pathology, and GlaxoSmithKline (GSK), today announced a strategic multi-year partnership to accelerate scientific research and drug development programs in oncology and non-alcoholic steatohepatitis (NASH) by leveraging PathAI’s technologies in digital pathology including the use of PathAI’s AIM-NASH tool.

Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th.